Kohesio: discover EU projects in your region

project info
Start date: 21 April 2020
End date: n/a
Project website: link
funding
Fund: European Regional Development Fund (ERDF)
Total budget: 420 598,04 €
EU contribution: 210 299,02 € (50%)
programme
Programming period: 2014-2021
Managing authority: Direzione Generale "Ricerca, Innovazione, Università, Export, Internazionalizzazione" - Unità Organizzativa "Autorità di Gestione POR FESR 2014-2020"

EPIGENETIC THERAPY FOR THE TREATMENT OF CORONAVIRUS INFECTIONS

BACKGROUND. SARS-COV-2 HAS A SINGLE FILAMENT RNA GENOME. AFTER ENTERING THE TARGET CELL, THE VIRUS BEGINS THE PHASES OF REPLICATION OF ITS GENOME AND SYNTHESIS OF THE NECESSARY PROTEINS. THE EPITHELIAL CELLS OF THE AIRWAY AND THE CELLS OF THE INNATE IMMUNITY (MACROPHAGES) ARE THE MAIN TARGETS OF THE VIRUS. DURING THE REPLICATION OF THE SARS-COV-2 VIRUS, DOUBLE-STRANDED RNA (DSRNA) IS GENERATED, LEADING TO THE ACTIVATION OF VARIOUS DSRNA-SENSING MECHANISMS. THE RESPONSE GENERATED INDUCES THE SYNTHESIS OF INTERFERONS, CHEMOKINES, CYTOKINES AND ON-SITE MIGRATION OF IMMUNE SYSTEM CELLS THAT AMPLIFY AND REFINE THE INITIAL RESPONSE. CORONAVIRUSES EXPRESS PROTEINS THAT ARE ABLE TO INACTIVATE DSRNA-SENSING MECHANISMS, TRIGGERING THE OVERALL DEREGULATION OF THE RESPONSE TO VIRAL INFECTION LEADING TO FURTHER DAMAGE RESULTING FROM EXCESSIVE TISSUE INFLAMMATION AND INEFFECTIVE RESPONSE OF SOME POPS

Flag of Italy  Multiple locations, Italy